# Liliana Nordbakk

> Liliana Nordbakk is a Series B investor at Neva SGR (San Jose) backing Medical and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Neva SGR](https://shizune.co/investors/profile/neva-a608)
- Location: San Jose, United States
- Total investments: 1
- Last investment: Jul 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/liliana-nordbakk/64/21/64b

Liliana Nordbakk is a Series B investor at Neva SGR in San Jose focused on Medical and Health Care. Serial entrepreneur and investor in high-tech and biotech companies, with a demonstrated history of building several companies from inception to IPO. Her experience as an entrepreneur and executive comes from building companies that develop Big Data and Artificial Intelligence software products. She co-founded these companies and grew them as anexecutive to exit them either in a trade sale or (IPO). Experienced in investing for more than a decade of building a successful angel investment portfolio with the angel investment group Band of Angels, LLC in San Francisco. As a hands-on investor, Liliana mentors her portfolio companies in the areas of my expertise which are Biotechnologies, Business Development, Corporate Strategy, Management, and Finance.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nuclidium | NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics. | $131.8M | Series B | Jul 10, 2025 |  |

1 of 1 investments shown.

## Co-investors
- [Angelini Ventures](https://shizune.co/investors/profile/angelini-ventures) — VC Fund, 1 deal together
- [Bayern Kapital](https://shizune.co/investors/profile/bayern-kapital) — VC Fund, 1 deal together
- [DeepTech & Climate Fonds](https://shizune.co/investors/profile/deeptech-climate-fonds) — VC Fund, 1 deal together
- [Eurazeo](https://shizune.co/investors/profile/eurazeo-com) — VC Fund, 1 deal together
- [Highlight Capital](https://shizune.co/investors/profile/highlight-capital-llc) — VC Fund, 1 deal together
- [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners) — VC Fund, 1 deal together

## About Neva SGR

VC Fund · Turin, Italy

Neva SGR, part of the Intesa Sanpaolo Group and wholly owned by the Intesa Sanpaolo Innovation Center, plans and manages investment funds for professional investors interested in seizing diversification and high-yield opportunities offered by Venture Capital investments. Neva SGR can count on Intesa Sanpaolo Innovation Center’s and Intesa SanpaoloGroup’s strength, financial resources, know-how and network of relationships, a unique source of value on the market. Neva SGR is the perfect blend of strength, reputation and stability of the Intesa Sanpaolo Group and the best practices of international venture capital firms. Neva SGR aims to boost the Italian economy through new technologies and to be market maker of the VC asset class of venture capital in Italy.

5 contacts available at Neva SGR.

| Name | Title | Profile |
| --- | --- | --- |
| Alberto Greppi | Senior Investor | https://shizune.co/investors/profile/alberto-greppi |
| Cosimo Scarinci | Investment Team Member | https://shizune.co/investors/profile/cosimo-scarinci |
| Antonio Chiarello | Key Man - NEVA FIRST Fund | https://shizune.co/investors/profile/antonio-chiarello |
| Liliana Nordbakk | Partner | https://shizune.co/investors/profile/liliana-nordbakk |
| Mario Costantini | CEO | https://shizune.co/investors/profile/mario-costantini |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Liliana Nordbakk invest in?

Liliana Nordbakk invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Liliana Nordbakk last invest?

The most recent investment recorded for Liliana Nordbakk closed in Jul 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co